Impact of d-pinitol on the attenuation of proinflammatory cytokines, hyperglycemia-mediated oxidative stress and protection of kidney tissue ultrastructure in streptozotocin-induced diabetic rats

Chemico-Biological Interactions

Volumn 188, Issue 1, 2010, Pages 237-245

  Sivakumar, Selvaraj ^a   Palsamy, Periyasamy ^a   Subramanian, Sorimuthu Pillai ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

D Pinitol; Diabetic kidney; Lipid peroxidation; Oxidative stress; Streptozotocin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ASCORBIC ACID; CARBONYL DERIVATIVE; CATALASE; CREATININE; CYCLITOL; CYTOKINE; DEXTRO PINITOL; GLICLAZIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HYDROPEROXIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID PEROXIDE; NITRITE; PROTEIN; PROTEIN CARBONYL; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA; URIC ACID; INOSITOL; PINITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFICACY; ENZYME INHIBITION; HISTOPATHOLOGY; HYPERGLYCEMIA; KIDNEY PARENCHYMA; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; TISSUE LEVEL; TREATMENT DURATION; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; METABOLISM; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; INOSITOL; KIDNEY; MICROSCOPY, ELECTRON, TRANSMISSION; OXIDATIVE STRESS; RATS; STREPTOZOCIN;

GLYCINE MAX; RATTUS;

EID: 77956174464     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.07.014     Document Type: Article

References (66)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
2. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
3. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999, 48:1-9.
4. Baliga R., Ueda N., Walker P.D., Shah S.V. Oxidant mechanisms in toxic acute renal failure. Drug Metab. Rev. 1999, 31:971-997.
5. Fiorillo C., Oliviero C., Rizzuti G., Nediani C., Pacini A., Nassi P. Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis. Clin. Chem. Lab. Med. 1998, 36:149-153.
6. Hahn S., Krieg R.J., Hisano S., Chan W., Kuemmerle N.B., Saborio P., Chan J.C. Vitamin E suppresses oxidative stress and glomerulosclerosis in rat remnant kidney. Pediatr. Nephrol. 1999, 13:195-198.
7. Melhem M.F., Craven P.A., Liachenko J., DeRubertis F.R. Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J. Am. Soc. Nephrol. 2002, 13:108-116.
8. Anjaneyulu M., Chopra K., Quercetin an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 2004, 31:244-248.
9. Sharma S., Kulkarni S.K., Chopra K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 2006, 33:940-945.
10. Streeter J.G., Lohnes D.G., Fioritto R.J. Patterns of pinitol accumulation in soybean plants and relationships to drought tolerance. Plant Cell Environ. 2001, 24:429-438.
11. Phillips D.V., Dougherty D.E., Smith A.E. Cyclitols in soybean. J. Agric. Food Chem. 1982, 30:456-458.
12. Keller F., Ludlow M.M. Carbohydrate metabolism in drought-stressed leaves of pigeon pea (Cajanus cajan). J. Exp. Bot. 1993, 44:1351-1359.
13. Paul M.J., Cockburn W. Pinitol, a compatible solute in Mesembryanthemum crystallinum L.?. J. Exp. Bot. 1989, 40:1093-1098.
14. Gomesa C.I., Obendorfa R.L., Horbowiczb M. Myo-inositol, d-chiro-inositol, and d-pinitol synthesis, transport, and galactoside formation in soybean explants. Crop Sci. 2005, 45:1312-1319.
15. Streeter J.G Carbohydrates in soybean nodules: II. Distribution of compounds in seedlings during the onset of nitrogen fixation. Plant Physiol. 1980, 66:471-476.
16. Singh R.K., Pandey B.L., Tripathi M., Pandey V.B. Anti-inflammatory effect of (+)-pinitol. Fitoterapia 2001, 72:168-170.
17. Geethan P.K., Prince P.S. Antihyperlipidemic effect of d-pinitol on streptozotocin-induced diabetic Wistar rats. J. Biochem. Mol. Toxicol. 2008, 22:220-224.
18. Kim J.I., Kim J.C., Kang M.J., Lee M.S., Kim J.J., Cha I.J. Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study. Eur. J. Clin. Nutr. 2005, 59:456-458.
19. Lee J.S., Lee C.M., Jeong Y.I., Jung I.D., Kim B.H., Seong E.Y., Kim J.I., Choi I.W., Chung H.Y., Park Y.M. d-pinitol regulates Th1/Th2 balance via suppressing Th2 immune response in ovalbumin-induced asthma. FEBS Lett. 2007, 581:57-64.
20. Lee J.S., Jung I.D., Jeong Y.I., Lee C.M., Shin Y.K., Lee S.Y., Suh D.S., Yoon M.S., Lee K.S., Choi Y.H., Chung H.Y., Park Y.M. D-pinitol inhibits Th1 polarization via the suppression of dendritic cells. Int. Immunopharmacol. 2007, 7:791-804.
21. Sivakumar S., Subramanian S.P. D-pinitol attenuates the impaired activities of hepatic key enzymes in carbohydrate metabolism of streptozotocin-induced diabetic rats. Gen. Physiol. Biophys. 2009, 28:233-241.
22. Sivakumar S., Subramanian S.P. Pancreatic tissue protective nature of D-Pinitol studied in streptozotocin-mediated oxidative stress in experimental diabetic rats. Eur. J. Pharmacol. 2009, 622:65-70.
23. Sivakumar S., Palsamy P., Subramanian S.P. Attenuation of oxidative stress and alteration of hepatic tissue ultrastructure by d-pinitol in streptozotocin-induced diabetic rats. Free Radic. Res. 2010, 44:668-678.
24. Rakieten N., Rakieten M.L., Nadkarni M.V. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 1963, 26:91-98.
25. Fischer L.J., Rickert D.E. Pancreatic islet-cell toxicity. CRC Crit. Rev. Toxicol. 1975, 3:231-263.
26. Natelson S., Scott M.L., Beffa C. A rapid method for the estimation of urea in biologic fluids. Am. J. Clin. Pathol. 1951, 21:275-281.
27. Caraway W.I. Uric acid. Standard Methods of Clinical Chemistry 1963, 239-247. Academic Press, NY. D. Seligson (Ed.).
28. Brod J., Sirota J.H. The renal clearance of endogenous " creatinine" in man. J. Clin. Invest. 1948, 27:645-654.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
30. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
31. Omaye S.T., Turnbull J.D., Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol. 1979, 62:3-11.
32. Desai I.D Vitamin E analysis methods for animal tissues. Methods Enzymol 1984, 105:138-147.
33. Sedlak J., Lindsay R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 1968, 25:192-205.
34. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
35. Jiang Z.Y., Hunt J.V., Wolff S.P. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal. Biochem. 1992, 202:384-389.
36. Uchida K., Stadtman E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction. J. Biol. Chem. 1993, 268:6388-6393.
37. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247:3170-3175.
38. Takahara S., Hamilton H.B., Neel J.V., Kobara T.Y., Ogura Y., Nishimura E.T. Hypocatalasemia: a new genetic carrier state. J. Clin. Invest. 1960, 39:610-619.
39. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
40. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
41. Carlberg I., Mannervik B. Glutathione reductase. Methods Enzymol. 1985, 113:484-490.
42. Schnedl W.J., Ferber S., Johnson J.H., Newgard C.B. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 1994, 43:1326-1333.
43. Elsner M., Guldbakke B., Tiedge M., Munday R., Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 2000, 43:1528-1533.
44. Bennett R.A., Pegg A.E. Alkylation of DNA in rat tissues following administration of streptozotocin. Cancer Res. 1981, 41:2786-2790.
45. Ohkuwa T., Sato Y., Naoi M. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci. 1995, 56:1789-1798.
46. Okawa H., Doi K. Neoplastic lesions in streptozotocin-treated rats. Jikken Dobutsu 1983, 32:77-84.
47. Koenig R.J., Cerami A. Hemoglobin A Ic and diabetes mellitus. Annu. Rev. Med. 1980, 31:29-34.
48. Mauer S.M., Steffes M.W., Brown D.M. The kidney in diabetes. Am. J. Med. 1981, 70:603-612.
49. Madianov I.V., Balabolkin M.I., Markov D.S., Markova T.N. Main causes of hyperuricemia in diabetes mellitus. Ter. Arkh. 2000, 72:55-58.
50. Forbes J.M., Cooper M.E., Oldfield M.D., Thomas M.C. Role of advanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol. 2003, 14:S254-S258.
51. Soulis T., Cooper M.E., Sastra S., Thallas V., Panagiotopoulos S., Bjerrum O.J., Jerums G. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats. Diabetologia 1997, 40:1141-1151.
52. McLay J.S., Chatterjee P., Nicolson A.G., Jardine A.G., McKay N.G., Ralston S.H., Grabowski P., Haites N.E., MacLeod A.M., Hawksworth G.M. Nitric oxide production by human proximal tubular cells: a novel immunomodulatory mechanism?. Kidney Int. 1994, 46:1043-1049.
53. Ho E., Bray T.M. Antioxidants, NFkappaB activation, and diabetogenesis. Proc. Soc. Exp. Biol. Med. 1999, 222:205-213.
54. Dong X., Swaminathan S., Bachman L.A., Croatt A.J., Nath K.A., Griffin M.D. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 2007, 71:619-628.
55. Pfeilschifter J., Rob P., Mülsch A., Fandrey J., Vosbeck K., Busse R. Interleukin 1 beta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur. J. Biochem. 1992, 203:251-255.
56. Dalla Vestra M., Mussap M., Gallina P., Bruseghin M., Cernigoi A.M., Saller A., Plebani M., Fioretto P. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J. Am. Soc. Nephrol. 2005, 16(Suppl. 1):S78-S82.
57. Geerlings S.E., Brouwer E.C., Van Kessel K.C., Gaastra W., Stolk R.P., Hoepelman A.I. Cytokine secretion is impaired in women with diabetes mellitus. Eur. J. Clin. Invest. 2000, 30:995-1001.
58. Davì G., Falco A., Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid. Redox Signal. 2005, 7:256-268.
59. Wong C.M., Cheema A.K., Zhang L., Suzuki Y.J. Protein carbonylation as a novel mechanism in redox signaling. Circ. Res. 2008, 102:310-318.
60. Thomas C.E., Reed D.J. Radical-induced inactivation of kidney Na+, K(+)-ATPase: sensitivity to membrane lipid peroxidation and the protective effect of vitamin E. Arch. Biochem. Biophys. 1990, 281:96-105.
61. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 1988, 263:17205-17208.
62. Gumieniczek A. Effects of repaglinide on oxidative stress in tissues of diabetic rabbits. Diabetes Res. Clin. Pract. 2005, 68:89-95.
63. Jessup W., Dean R.T., de Whalley C.V., Rankin S.M., Leake D.S. The role of oxidative modification and antioxidants in LDL metabolism and atherosclerosis. Adv. Exp. Med. Biol. 1990, 264:139-142.
64. Maritim A.C., Sanders R.A., Watkins 3rd J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 2003, 17:24-38.
65. Matés J.M., Sánchez-Jiménez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front. Biosci. 1999, 4:D339-D345.
66. Negre-Salvayre A., Salvayre R., Augé N., Pamplona R., Portero-Otín M. Hyperglycemia and glycation in diabetic complications. Antioxid. Redox Signal. 2009, 11:3071-3109.